Directory · CN
Biotechnology in China
A register of firms and the professionals working at them in the Biotechnology sector based in China. Browse the public index, then filter or export on Kipplo.
Companies
312 on file
Jw Therapeutics
JW Therapeutics (HKEx: 2126) is an independent, innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products. Since its founding in 2016, the company has built an integrated platform and pipeline spanning hematologic malignancies, solid tumors and autoimmune diseases. As a commercial-stage CAR-T company, JW Therapeutics is committed to bringing breakthrough, high-quality cell therapies such as Carteyva® to patients in China and beyond, improving survival and quality of life and advancing the healthy, standardized development of the cell therapy industry.
201 to 500 staff
Exuma Biotech
EXUMA Biotech is a clinical-stage biotechnology company developing next-generation in vivo cell and gene therapies. Founded in 2015, the company is focused on creating safe, scalable, and accessible therapies that eliminate traditional barriers to CAR-T treatment. Headquartered in West Palm Beach, Florida with operations across the Cayman Islands and Asia, EXUMA takes a globally integrated approach to science and development. Our mission is to create safe, effective, and accessible therapies through platforms designed for high-throughput discovery, tumor-specific targeting, and point-of-care delivery.
51 to 200 staff
Angel Yeast Fermentation Nutrients
To satisfy the needs for organic nitrogen sources in the bio-fermentation industry, including fermentation of biological pharmaceuticals, amino acids, probiotics, enzymes, etc, Angel Yeast has developed safe, efficient, clean, stable yeast extracts, yeast peptone, inactive yeast, and culture media. https://en.angelyeast.com/products/microbial-nutrition.html
10001+ staff
Bota Biosciences
Bota Biosciences (Bota Bio) is a global industrial biotechnology company connecting biological design to scale-up manufacturing to accelerate shifts to sustainable living. Bota has built an integrative bioengineering platform, to develop and implement efficient, eco-friendly, and cost-effective biomanufacturing technologies. Committed to its mission, Bota established its own pilot plant and manufacturing facility, affirming its dedication to offering scalable industrial solutions and market-ready products. This infrastructure strengthens support for customers and partners across industries such as nutrition, food, personal care, and animal health. Powered by a dynamic, multidisciplinary team, Bota Bio channels biotech innovations to create a global impact. The company's Series B financing has surpassed $100 million, bringing its aggregate funding to $145 million, with investment from notable strategic and financial investors, including Hong Shan Capital, Matrix Partners, and BASF Ventures.
51 to 200 staff
Shanghai Junshi Biosciences Co Ltd
Junshi BioPharma is an innovation-driven biopharmaceutical company which is dedicated to the discovery and development of innovative drugs and their clinical research and commercialization on a global scale. Our mission is to provide patients with treatment options that work better and cost less. Based on the core platform technology of protein engineering, Junshi stands at the frontier of R&D of macromolecular drugs. With distinguished capability of innovative drug discovery, advanced biotechnological R&D, large-scale production capacity on the full industry chain and rapidly expanding drug candidate portfolio of tremendous market potential, Junshi has a leading edge in the PRC in the emerging field of immuno-oncology and for the treatment of autoimmune and metabolic diseases. Junshi is the first PRC company filing IND application and NDA application to the NMPA for anti-PD-1 monoclonal antibody, and also the first PRC company to receive IND approvals from the NMPA for anti-PCSK9 monoclonal antibody and anti-BLyS monoclonal antibody. Our vision is to become a pioneer in the area of translational medicine by developing first-in-class and best-in-class drugs through original innovation. With enrichment of our product pipelines and exploration of drug combination therapies, Junshi expanded its innovation to the R&D of more types of drugs, including small molecule drugs and antibody drug conjugates (or ADCs), as well as to the exploration of the next-generation innovative therapies for cancer and autoimmune diseases.
1001 to 5000 staff
Bioeasy Biotechnology
Shenzhen Bioeasy Biotechnology Inc, a leading provider of food safety, animal health and public health products. We are dedicated to provide the easy, simple, reliable, quality assurance and affordable rapid test to the global market for over 15 years, and help people have easy access to those reliable food diagnostics, animal diagnostics and clinical diagnostics products on time! Advantages- Strong R&D - insists on the way of self-innovation and steadily development- Reliable and high quality products, obtain CE, FDA, CLIA WAIVED, AQSIQ qualification, certificated by AOAC, ILVO and others- OEM - Ideal for exporters to China
501 to 1000 staff
Dalian Polytechnic University
Dalian Polytechnic University, formerly known as Dalian Institute of Light Industry, is the key construction university of Liaoning Province, “Excellence Plan” and “2011 Plan”, and the first batch of pilot universities for the reform of agricultural and forestry personnel education and training plan. Founded in 1958, the school was one of the first four light industry colleges established in China. It was originally affiliated to the Ministry of Light Industry and was placed under the administration of Liaoning Province in 1998.
10001+ staff
Hsf Biotech
As a high-tech biotechnology company, HSF Biotech is high-quality ingredient solutions manufacturer for human better life. Based on R&D and innovation, We serve multiple industries, such as dietary supplements, food and beverage, pharmaceutics, personal care products, animal nutrition in the global markets. As one of the global plant sterols/esters suppliers, HSF is an important pioneer in China's phytosterol/ester industry, a market promoter and a participant in the formulation of national industry standards. In 2022, HSF launched new innovations on fermentation technology, which have created a rapid and healthy growth in global reputation and technology accumulation. Covered Products Fermtek™ Fermentation Series | LowChol™ Phytosterol | VegeToco™ Natural Vitamin E | VegeLipi™ Micro-encapsulated Lipid Powder | SoliPro™ Micro-encapsulated Solid Powder | NatenFla™ Natural Flavors | VegeNutri™ Nutrition Ingredients | NutraColor™ Natural Color | NatoDant™ Natural Anti-Oxidant | PhytoSweet™ Sweeteners Our products cover the research and development, manufacture and sales of a multiple series of products: plant sterols/esters, natural vitamin E, functional powder/oil microencapsulation, natural pigments, fermenation product and ferulic acid. HSF is certified with the ISO 9001 standard and ISO FAMI-QS, SC, HALAL, Kosher, IP(NON-GMO), cGMP and ORGANIC(NOP/EOS), etc. Product Development & Solution Contract Manufacturing | Customized Ingredients Solution | Blend and Premix | Patenting and Functional Evaluation Providing systematic product solutions to global customers in the nutrition and health field. HSF has a number of independent R&D and industrialization technical teams. We have core patented technologies in a number of cutting-edge biotechnology and life science fields. HSF is committed to taking the road of technological innovation and technology first.
51 to 200 staff
Carterra
Carterra® is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra's high throughput LSA, LSA-XT, and Ultra platforms for monoclonal antibody (mAb) and small molecule screening and characterization combine patented microfluidics technology with real-time High-Throughput Surface Plasmon Resonance (HT-SPR) and industry-leading analysis and visualization software. These systems deliver up to 100 times the throughput in 10% of the time while using only 1% of the sample compared to existing label-free platforms. The LSA-XT and Ultra instruments introduce enhancements to Carterra’s flagship product, the LSA, increasing sensitivity and enabling new applications in biotherapeutic discovery and small molecule analysis. Carterra, Inc. is based in Salt Lake City, Utah, and has Customer Experience Centers in San Francisco, Salt Lake City, Boston, Manchester, England, and Munich, Germany. Carterra products are available in Asia-Pacific and Oceania through our exclusive distributor, Revvity. For additional information, please visit
51 to 200 staff
Chongqing Zhifei Biological Products Co., Ltd
Chongqing Zhifei Biological Products is a biotechnology company based out of CHONGQING, CQ | Chongqing, China.
1 to 10 staff
Bsbe
BSBE is a Chinese leading provider of in-vitro diagnostics (IVD) products and service, there are biochemistry reagents, coaguation reagents and instrument, blood grouping cards and instrument, etc. BSBE was established in 2001, focusing on R&D, manufacturing and sales of IVD products which reach to international advanced level. BSBE was registered in Beijing, the capital of China with the registered capital of RMB501,787,943 and successfully listed on GEM in Shenzhen with the stock code 300406 in 2014. As a Chinese leader in IVD filed, BSBE is engaged in developing the best IVD testing platform. And till now, BSBE has the system of clinical biochemistry testing, coagulation testing and blood typing. Due to the steady progression and rich experience in the years, BSBE has a worldwide sales and marketing network. BSBE is focused on the R&D of IVD products and it has a high qualified R&D team. Under the guidance of the experts, BSBE has established clinical biochemistry platform of enzymatic method (including enzymatic cycling method), immunoturbidimetric method, latex immunoturbidimetric method, CEDIA method, EMIT method; Meanwhile, BSBE has very strong R&D team on liquid coagulation reagents. In 2018, BSBE launches its blood typing system using the DG Gel card technology.
501 to 1000 staff
Sironax
Sironax is a global clinical-stage biotechnology company committed to promoting healthier aging by discovering and developing novel treatments for degenerative diseases affecting longevity, diseases requiring supportive care, and certain autoimmune immunology and inflammation diseases. Sironax has three proprietary clinical-stage programs with first-in-class or best-in-class assets, and several undisclosed preclinical programs. The company’s research targets key contributors of aging: dysregulated cellular death, uncontrolled inflammation, and disrupted energy homeostasis. Sironax is headquartered in Waltham, Massachusetts, with comprehensive research centers in Beijing and Shanghai, China, and additional operations in Basel, Switzerland and Sydney, Australia. For more information, visit sironax.com.
51 to 200 staff
Jland Biotech
Jiangsu Jland Biotech Co, Ltd is a company dedicated to the development and production of Biollagen™ collagen. We design and develop Pichia engineering yeast and aim at improving hydrophilicity and eliminating immunogenicity. Non-Animal derived collagen has many advantages over animal-derived collagen & has multiple applications in cosmetic & Pharmaceutical applications
201 to 500 staff
Obio Tech
Established in 2013, OBiO Technology leads the way in gene and cell therapy as a pioneering CRO and CDMO. Our expertise spans vectorology studies, functional genomics, PD, AD, GMP production, as well as IND-enabling CMC and clinical and commercial manufacturing, provides comprehensive solutions internationally and tailored services for your needs. 🧬 GMP production: State-of-the-art ft 2) facility for global supply. 🧬 We specialize in vectorology studies, functional genomics, PD and AD, ensuring Investigational New Drug (IND) readiness and supporting all phases of clinical and commercial manufacturing. 🧬 From laboratory to clinic, we continuously advance your products, positively impacting populations worldwide. 🧬 Our unwavering commitment ensures the delivery of high quality CDMO services across the preclinical, IND, clinical, and commercial stages. 🧬Our expertise spans plasmids, mRNA, AAV, LVV, Ad viral vectors, cell therapy, CAR-T, NK, Treg, iPSCs, Exosome.Oncolytic virus, as well as cutting-edge technologies like inducible viral vector packaging, ultralow endotoxin processes, and AAVneo for tissue-specific AAV variants, etc. 🧬Trustful Expertise: 10+ years experience in Cell & Gene Therapy, over 40% master degree above holders. Do not hesitate to send an inquiry or question here: https://lnkd.in/g8BzXQfQ Phone:++1 781-748-4204 (U.S.) Email: bd@obiosh.com
501 to 1000 staff
Affamed Therapeutics
AffaMed Therapeutics is a clinical stage therapeutic company focused on developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmic, neurological and psychiatric disorders for patients in Greater China and around the world. The leadership team of AffaMed Therapeutics has gained deep industry expertise and an extensive track record in high-quality discovery, clinical development, regulatory affairs, manufacturing, commercial operations, and business development at leading multi-national pharmaceutical companies in China and globally.
51 to 200 staff
Kdn Biotech Shanghai Co., Ltd
Welcome to KDN Shanghai, where we are hard at work every day to replace traditional industrial processes with sustainable, environmentally-friendly and more innovative solutions. We owe it to the earth to do so. KDN Biotech is a leading enzyme company that specializes in the research, development, and manufacturing of high-quality enzymes for a variety of industries, including textile, household care, bioenergy, pulp & paper, animal nutrition, food enzyme. With a strong focus on innovation, quality, and customer satisfaction, KDN Biotech has earned a reputation as a trusted supplier of enzymes that meet the most demanding standards. Founded by a team of experienced scientists and entrepreneurs, KDN Biotech has 9 production bases, 8 technical centers, 2 laboratories, 32 Ph.Ds and about 300 Masters. This has enabled the company to develop a broad range of enzymes that can be customized to meet the specific needs of its customers. KDN Biotech's product portfolio includes a wide range of enzymes, including proteases, lipases, cellulase and specialty enzymes. At KDN Biotech, we are committed to sustainability and responsible manufacturing practices. Our enzymes are produced using eco-friendly processes and are derived from non-GMO sources. We strive to minimize our environmental impact and promote a sustainable future for all.
1001 to 5000 staff
Mytech
Chengdu Mytech Biotech Co, Ltd, Mytech in short, was founded in 2003 by a group of entrepreneurs with the ambition to become the world’s outstanding supplier of small peptides. In 2006, Mytech speed up its steps into global market. Mytech aims to provide better service to animal husbandry field and become a globalized animal nutrition company. The production line of Mytech is in compliance with GMP+ standard to ensure its better production process and good product quality. Nowadays, Mytech invested lots of efforts and funds on product development and application study, aiming to make better localization of product in different areas. Better for Animals Better for Human
51 to 200 staff
Pangoo Focus On Animal Natural Health
Business Type: Manufacturer, Trading Company Location: Hebei, China (Mainland) Main Products: Mycotoxin treatment,Pond Cleaner,Feed Probiotics,Feed Additives,Animal Supplement Total Employees: 501 - People Total Annual Revenue: Above US$100 Million Year Established: 2010 Top 3 Markets: Africa 23.00% Mid East 19.00% Southeast Asia 15.00% Certifications: ISO9001,ISO9001,FSC Product Certifications: Audited Supplier PANGOO - specialized taking care animal Health! Company philosophy: integrity deeds and thanksgiving society Factory was found in 1993. Registered Capital: RMB Fixed Asset: RMB Production Ability: MT / Year Certificates: Certificate of Food safety Management System Certification Certificates: Quality Managements System Certificate ISO 9001:2008 10615Q10106ROS Scientific research achievements: Development concept: Development green industry, to promote human health! Assumed the national "863" project of " Research bacteria and algae repair freshwater environment "" Genetically engineered bacteria to repair Pond Environmental Application Technology and Demonstration ", the project have won the "Hebei Science and Technology Progress Second Award"; Optional subjects of "The Study of Pro-Niceclean and Nitrate Treatment, and The technical research of ammonia, nitrite degradation"" The development and application of Construction of series probiotics for pond water phase", the subject have passed the provincial appraisal, and achieved to provincial and municipal science and technology progress awards. In 2011, in collaboration with the Chinese academy of sciences institute of Marine, shared the country's "12th five-year" science and technology support projects, namely the key technology research of Maritime Affairs and Fisheries Disease Prevention and Control (2011BAZ02709) October 18, 2013," The Development and Application of Viable particles sediment improver "" The development and application of Biological agents to destroy cyanobacteria "these two projects have been identified by the provincial level, and achieved leading in the domestic. Viable particles improved the pond bottom, the biological elimination of cyanobacteria and other products, the process and equipment of domestic initiative of liquid and solid, fully automatic fermentation, which has declared three national patents. Honor: Winning mentality: Proud of Pangoo! The advanced collective of national feed industry and technological progress High-tech biotechnology companies Key leading enterprises in agricultural industrialization management grade credit enterprise in Hebei Province The most popular Agricultural and Economics products for consumer In 2012, named science and technology innovation enterprise by Qingxian, and won the "Technology Innovation Award Top Ten integrity enterprises in Hebei Province At the same time, general manager lian shui Zhang was named "Outstanding scientific and technological leader"
51 to 200 staff
Tcrcure Biopharma Corp
TCRCure Biopharma Corp is a world-class, “One-Stop Shop” cell therapy operation built across the U.S. and China. We deliver the latest cell therapy advances directly to patients with solid tumors. As of 2021, we have treated more than 50 patients and built more than a dozen CAR-T/TCR-T pipelines. TCRCure’s cutting-edge platform technologies include antigen-specific TCR/CAR discovery, immune-cell engineering, and industry-scale viral vector production. We operate sq. ft. of specialized facilities on both sides of the Pacific, including scalable GMP capacity for cell production and viral manufacturing. TCRCure works closely with world-class hospitals in China and the United States for clinical research in different solid tumors. Current indications including cervical cancer, ovarian cancer, nasopharyngeal carcinoma, lung squamous carcinoma, melanoma, sarcoma, endometrial cancer, and brain cancer.
51 to 200 staff
Wesail Biotech
Company Introduction: WESAIL Biotech Contact Email: sales@wesailbio.com Wesail Biotech, with over 20 years of experience, is a leading innovator in the IVD industry, providing high-performance reagents and analyzers, including colloidal gold and immunofluorescence platforms. We specialize in POCT solutions for cardiovascular health, metabolism, fertility, inflammation, diabetes, hormones, and more. During the pandemic, our COVID-19 self-test kits gained global recognition, including: CE0123 Certification (TUV SUD), Germany PEI Approval, and French ANSM Registration. Our POCT products are widely used in emergencies. Cardiac markers high sensitive Troponin-I test in 8 mins in whole blood (no serum separation). HbA1c CV is within 5%. VD test takes 15 mins with both NGSP and IFCC certification. Our products are trusted across Europe, Latin America, and the Middle East, with leading hospitals in Italy recognizing their exceptional performance. We hold global certifications, including US FDA and European IVDR. As a global leader in the Point-of-Care Testing, Wesail Biotech is committed to pushing the boundaries of healthcare innovation to the next level.
51 to 200 staff
Acerchem International
As a leading group in Health & Nutraceutical industry, Acerchem provides a variety of solutions from innovative ingredients, contract manufacturing, supply chain, formulation, and capsules. Our business is covering more than 40 countries in nutritional supplement, functional foods and beverage, beauty care and animal nutrition markets. Our offices in UK, Japan, Netherlands, Spain have contributed in an extensive way to local Health & Nutraceutical industry. We keep our mission "Create value for health, Bring Nutrition to life" to all our customers, partners, and suppliers. Our global souring and supply chain service have brought splendid value to our customers, with JIT delivery, strict quality control, and passionate after-sales service.
51 to 200 staff
Anhui Huaheng Biotechnology Co., Ltd
Key words: AMINO ACID, ALANINE, ARBUTIN, MANUFACTURER. Anhui Huaheng Biological Engineering Co, Ltd. was established in April 2005, is a professional engaged in amino acids and other organic acid product development, production and sales of national Torch key high-tech enterprises. The company has successfully undertaken the "863" project of the Ministry of Science and Technology of the Twelfth Five-Year Plan, the National Demonstration Project of the Biological Industry of the National Develop mentand Reform Commission, the Enterprise Technology Innovation Fund of the Ministry of Science and Technology, and other high-tech industrialization projects. It is an international leader in the production of L-Alanine technology and industrialization of enterprises. Our products are mainly used in medicine and health care products, daily chemicals,food and food additives and other fields.Upholdingthe concept of green, relying on technological breakthroughs and cost advantages, We providing services for the world's top 500 and industry leaders, including many domestic and international first-class customers.
501 to 1000 staff
Biosino Bio-Technology & Science Inc
BioSino is a leading high-technology enterprise whose major national controlling stakeholders comprise the Chinese Academy of Sciences, Beijing Municipal Government and Shanghai Municipal Government. Biosino has already become the largest manufacturer of IVD reagents in China after 20 years development. BioSino successfully finished IPO in GEM of Hong Kong Stock in 2006. Biosino's diagnostic products including clinical chemistry, immunology assay, molecular diagnostics, and rapid tests. BioSino has developed over 600 distributors and retailers over the China, occupy 75% of the Chinese market. The diagnostic products exported to over 50 countries from Southeast Asia, Middle-east, North Africa, and South America. BioSino has a professional after sales service team comprising experts in the field of biochemistry, immunology, pharmacy and medicine. It provide on-the-spot technological support and service to our customers, teach them how to use our products and resolve problems they meet.
201 to 500 staff
Changsha Comext Biotech Co.,ltd
Comext is an enterprise of raw materials supply to the health science area that encompasses Food, Nutraceutical, Pharmaceutical, Cosmetic, and Feed Additive markets. Our core competencies are the quality assurance and international regulatory support with the professional production and R&D team, and the solid cooperation with professional third-party labs, such as Eurofins, SGS, Pony, TUV and so on. We treat the Product Quality First, Customer Service Frist as our Business Value. Mission - To create value for customers by developing and supplying products with the best quality, service and price- To promote a corporate culture based on the daily effort, training, entrepreneurship and professionalism of the team, and an intensive R&D platform to develop proprietary products as drivers for growth- To contribute to improving quality of life by providing expertise and services in the development of affordable drugs that meet society´s needs.
51 to 200 staff
Quacell Biotechnology, Co., Ltd
QuaCell Biotechnology, Co. Ltd.(QuaCELL) is an international contract research organization (CRO) and contract manufacturing organization (CMO) specializing in biologics development and production. Our cell culture platform technology provides us with advantages in antibody/recombinant protein engineering, cell line development, cell culture media & process development, and recombinant protein production. Services can be fully integrated to create a “DNA to IND” one-stop solution for all of our customers’ molecular biology, cell line, and protein needs. With facilities located in the heart of Zhongshan City in Guangdong, QuaCELL houses the Cell Culture Training Center of Excellence. It has developed numerous in-house technology platforms to provide cost-effective and high quality services to our customers. Our production processes are SOP-based and high-throughput, and have been streamlined to be exceptionally efficient on both a small and large scale. Each project is actively managed by a dedicated scientific director and a project manager to ensure timely completion with superior results that meet or exceed our clients’ expectations.
51 to 200 staff
Shandong Rotex Machinery Co,ltd
Shandong Rotex Machinery is located in Jinan, Shandong, China, and is a professional manufacturer mainly engaged in designing, manufacturing and exporting biomass pellet making machine such as wood pellet machine, straw pellet machine, sawdust pellet machine, etc. Our factory has a specialized R&D department and a dedicated export sector. ROTEX has obtained, ISO9001, CE Certification on its Pellets Machine YGKJ560, YGKJ680, YGKJ850, YGKJ1050. Based on high technology, superior after-sales services and more than 10 years of hard efforts, ROTEX products have enjoyed great popularity among clients in domestic and overseas markets. Our pellet making machine has exported to Egypt, Malaysia, Vietnam, Thailand, Finland, Costa Rica, south Africa, Argentina, Bulgaria, Russia and Poland,Turkey, Hungary, UAE, Slovenia, etc. We provide professional after sale service and 24 hours online service for our customers. Your installation will be carried out and guided by our professional technician and engineers. ROTEX has been attaching great importance to the quality and reputation. Our aim is to do our best to satisfy the needs of our customers. We regard "reputation is the most precious thing" as our aim. We are looking forward to working with overseas customers based on mutual benefits. Please feel free to contact us for more details. Welcome you come to visit our factory at your convenience.
201 to 500 staff
Suzhou Vdo Biotech Co.,ltd
VDO Biotech Co, Ltd. is a high-tech biotechnology company focused on advanced microsphere technologies and downstream bioprocessing solutions for global life science and biopharmaceutical customers. Founded in 2014 and headquartered in BioBAY, Suzhou Industrial Park, VDO Biotech delivers integrated solutions spanning precision microspheres, biomacromolecule separation and purification, and nano-flow cytometry, supporting applications from in vitro diagnostics to biologics manufacturing and quality control. Our core products include: • Precision microspheres (magnetic, latex, fluorescent) for IVD applications • Chromatography resins (IEX, SEC, Protein A/G) trusted by global biopharma partners • Nano-flow cytometry solutions, including Exoplorer™, for exosome and virus analysis With ISO-certified manufacturing, a m² R&D facility, and a global partner network serving customers in over 50 countries, VDO Biotech is committed to delivering reliable, scalable, and high-performance tools that enable accurate diagnostics and high-quality biologics production.
501 to 1000 staff
Chengdu Huitai Biomedicine Company
Chengdu HUITAI Biomedicine is a clinical-stage biotech company focused on developing pan anti-fibrotic peptides through novel TGF-β technology. Unlike conventional TGF-β inhibitors that target integrins or TGF-β directly, HUITAI's lead asset, HTPEP-001, selectively antagonizes the interaction between TSP-1 and CD36 to block TGF-β1 activation. This mechanism preserves antifibrotic efficacy while markedly expanding the therapeutic safety window. Inhaled HTPEP-001 has demonstrated significant efficacy in reducing active TGF-β1 and alleviating lung fibrosis in preclinical animal models, with a safety margin exceeding 50-fold. The Phase I clinical trial confirmed its excellent safety and tolerability profile in humans, positioning inhaled HTPEP-001 as a promising therapeutic candidate for PF-ILD and IPF treatment.
11 to 50 staff
Dynamiker Biotechnology Tianjin Ltd
Dynamiker Biotechnology, founded in March of 2014, is a high-tech enterprise integrated with R&D, production and sales globally. It focuses on developing early and rapid in-vitro diagnostics of invasive fungal diseases (IFD). Headquarters is located at Tianjin. R&D Team: By adhering to the principle of “Technology is Power”the R&D team is consisted of domestic and overseas talented experts specialized in IVD, microbiology, immunology, molecular biology and clinical chemistry. Dr. Zeqi Zhou, as CTO of the team, obtained Ph.D. from Ohio University and Postdoc at Harvard Medical School. With the extensive experience gained at Bayer and Wyeth, he led the R&D team successfully have developed over 20 novel products for early diagnosis of IFD, which have shown strong competitiveness in global market. Market Opportunity: The goal of Dynamiker is to “shape company’s brand with high quality and penetrate world’s market with innovation”. The products are CFDA-cleared, CE-marked and registered in Turkey, India, Pakistan, Georgia, Egypt, Brazil, Mexico, Columbia etc. Those products have already launched into more than 480 hospitals domestically and over 30 hospitals globally. Customer Service: High quality is essential for market development and customer satisfaction. Dynamiker focuses on the needs of clients and continuously improves quality of after-sales service. Four level after-sales service support system has been established, including clinical centers, distributor's technical support team, Dynamiker's customer service team and the R&D team. That greatly makes us achieve our customers' trust and support. Our Vision Looking ahead, all of us are full of both confidence and dynamics. Dynamiker keeps upholding our enterprise spirit: “Unity, Practicability, Openness and Innovation". We are working together to make our company as a global l leader in IFD-IVD field, create an innovative international brand and have our IPO launched by 2020.
201 to 500 staff
Hangzhou Soy Medtech Co., Ltd
Hangzhou Soy MedTech Co, Ltd. is a professional medical diagnostic solutions provider in China. SoyMed is dedicated to the R&D and marketing of Medical diagnostic instruments and related Test kits, Home-use medical devices, and Lab consumables. Strict quality control and thoughtful customer service are our promises. Our team is always available to provide customers with better services. OEM and ODM services are also available. SoyMed - your reliable partner for medical diagnostic solutions.
1 to 10 staff
Health Gene Technologies Co., Ltd
Founded in August 2011, Ningbo Health Gene Technologies Co, Ltd.(HGT) is a leading high-tech company in nucleic acid molecular testing product development, manufacturing and services. Holding to the ideology of “Safer Society, Healthier Life”, HGT, standing on its own R&D driven by user demands, dedicates itself to provide premium solutions for multiplexed nucleic acid detection in precision medicine, individual identification and other related fields. A leading team of international talent Valuing talents with international background, HGT has built up its R&D team composed of about 70 people. Many core members are from renowned universities and/or multinational corporations with internationalized visions and unique experience in the fields of technology, marketing and management, etc. Top-notch facilities and hardware HGT has total m2 working space, with m2 of molecular diagnostics R&D laboratories and m2 of class C/D GMP-standard manufacturing workshops. It has a state-of-the-art R&D platform and advanced manufacture equipments. The management of production process is strictly guided by international and National Medical Products Administration (NMPA) manufacturing and quality control standards. Fulfil the unmet domestic need with competitive technologies and products HGT has become one of the largest suppliers of DNA testing kits for individual identification in the field of forensic science in China. It developed unique advantages in the field of precision medicine as well by the global first E6/E7 carcinogenic DNAs-based human papilloma (HPV) genotyping kit, and the only Multiplex Testing Kit for 13 Respiratory Pathogens in China.
201 to 500 staff
Qingdao Institute Of Bioenergy & Bioprocess Technology
QIBEBT aims to develop cutting-edge technologies in sustainable and renewable energy. Scientists and engineers in the QIBEBT develop and advance renewable energy technologies through a full R&D life-cycle: from basic scientific research to applied research and engineering. Our expertise spans from laboratory research, small-scale testing, scaling-up, to field demonstration.
201 to 500 staff
Shanghai Aidu Biotechnology Co., Ltd
Shanghai Aidu Biotechnology Co, Ltd. is committed to innovation in high-quality nutritional ingredients, delivering high-quality ingredients and solutions for the pharmaceutical, health food, and cosmetics industries. With a modern R&D center and advanced facility, analytical technologies, we ensure scientific precision and continuous improvement. Our global raw material sourcing network, built on nearly a decade of expertise, guarantees consistency and excellence from origin to final product. Guided by the principle of “Quality First, Customer Foremost,” we combine cutting-edge research with strict quality standards to support our partners worldwide. At Aidu, we are dedicated to creating Innovative Natural Solutions for Healthy Ageing and shaping a healthier future together.
51 to 200 staff
Syncozymes
Syncozymes is a leading Chinese company specializing in green process chemistry and biotransofromation in APIs' and intermediates' research, development and manufacture. Syncozymes is located in Shanghai International Medical Park, mainly engaged in R&D, fermentation, immobilization, protein engineering and applications of Enzymes. We are professional dealing with R&D and manufacture of APIs and INTERMEDIATES, synthesis design, process design and optimization. SYNCOZYMES is the first and the largest manufactory to produce coenzymes, NAD, NADP, NADH and NADPH in commercial scale in China. Syncozymes' clients and partners are top pharmaceutical companies in US, Europe, India and China. Syncozymes' management team is made of entrepreneurs with a combined over 30 years of leadership experience in top pharmaceutical and biotechnological companies in US and China. Our scientific teams include leading experts in fermentation, enzyme R&D, protein engineering and purification, medicinal chemistry, process chemistry, Green Chemistry and industrial biotransformation.
51 to 200 staff
Carsgen Therapeutics
CARsgen is a biopharmaceutical company with operations in China and the U.S. focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. The company has built an integrated cell therapy platform with in-house capabilities that span target discovery, antibody development, clinical trials, and commercial-scale manufacturing. CARsgen has internally developed novel technologies and a product pipeline with global rights to address major challenges of CAR T-cell therapies, such as improving the safety profile, enhancing the efficacy in treating solid tumors, and reducing treatment costs. Our vision is to become a global biopharmaceutical leader that brings innovative and differentiated cell therapies to cancer patients worldwide and makes cancer curable. Media contact: pr@carsgen.com
501 to 1000 staff
Epimab Biotherapeutics, Inc
EpimAb Biotherapeutics, Inc, is a China-based, privately held, start-up company founded in 2015 that is developing a portfolio of novel bi-specific antibodies in oncology and immune-oncology. All bispecifics are based on a proprietary platform, FIT-Ig (Fabs in Tandem). Multiple FIT-Igs have already been successfully generated binding to small, large, soluble or membrane-bound antigens with biochemical and biophysical properties similar to their parent monospecific antibodies. The first molecule, EMB-01, is a cMET/EGFR-inhibitor, that is in CMC development in collaboration with WuXi Apptec. EpimAb also has concluded licensing arrangements, e.g. with Kymab and Innovent Biologics, and is open to further partnerships. EpimAb has successfully concluded a Series A round of $25 MM with a consortium of international investors.
11 to 50 staff
Etern Therapeutics
ETERN was established in 2018, focusing on the research and development of small molecule drugs targeting protein liquid-liquid phase separation. The LLPS platform, the state-of-art protein liquid-liquid phase separation platform developed by Etern, integrate cutting edge techniques including protein phase separation biology, AI-based target identification and verification, phase separation-based phenotypic screening, image recognition-based hit finding, etc. The platform provides a novel strategy for drug R&D, especially for “undruggable"targets.
11 to 50 staff
Hl Powder
Hunan Hualiu New Material Co, Ltd.
51 to 200 staff
Innova Bio-Meditech
Innova Bio-Meditech is one of the professional global providers of laboratory and biopharma devices,focusing on biofermentation/water purification/air cleaning/freeze drying/glassware washing/cell culture. Firmly committed to our mission of "sharing innovative bio-meditech solutions with the world",we are dedicated to innovation in the fields of Biology Project,Life Science,Pharma Industry and Medical Treatment. For more information, please contact sales001@innobiomed.com “The passion for science”
51 to 200 staff
Jiangsu Yiming Biological Technology Co., Ltd
Jiangsu Yiming Biological Technology Co, Ltd, founded in August 1998, is a high-tech enterprise integrating R&D, manufacturing and sales. It boasts three modernized factories and one R&D base with a team of more than 30 professional researchers. The company mainly engaged in bio-engineering covering food additives and ingredients, medicine and other fields. The existing product line includes enzymes, colloid and preservatives, which are based on the biological fermentation of natural food additives. It is the first company in China to produce transglutaminase (TG) by microbial fermentation. Official Website: Twitter: https://twitter.com/YBiotech Youtube Channel:
201 to 500 staff
Oricell Therapeutics
Founded in 2015, Oricell Therapeutics aims to develop drugs with good efficacy and affordable prices to satisfy the globally unmet clinical needs through innovations and strives to become the world-leading developer of novel drugs for tumor immunotherapy.
51 to 200 staff
Shanghai Model Organisms Center, Inc
Founded in Shanghai Model Organisms Center Inc (SMOC) is dedicated to provide professional and comprehensive animal model services to global researchers. We offer customized solutions such as genetically engineered animal models, phenotype analysis and high-throughput screenings to advance life science research and drug discovery. SMOC owns a rapidly-growing repository of research-ready mouse models, including immunodeficient and humanized mouse models for cancer immunotherapy research. Our breeding facility is equipped with specific pathogen-free (SPF) cages which can accommodate up to rodents. Health and safety procedures for animal handling are strictly complied. Animal welfare is highly prioritized by SMOC.
201 to 500 staff
Shenzhen Lvshiyuan Biotechnology Co,ltd
Shenzhen Lvshiyuan Biotechnology Co,Ltd is a biotechnology company based at D Building, No.2 Industrial Avenue, Buxin Village, Buxin Community, Dapeng Subdistrict Office, Dapeng New District, Shenzhen 518120 China. It is a high-tech enterprise specializing in the development and production of the most advanced food safety test reagent, animal disease diagnostic reagent, In vitro diagnostic reagents(IVD) etc, committed to the industrialization of biological reagent around the world.
51 to 200 staff
Suzhou Medmay Biotechnology Co., Ltd
Medmay Biotech Group is a global comprehensive innovative enterprise focusing on R&D, production and trade of clinical in-vitro diagnostic products, medical consumables and general laboratory equipment. The head office is in Suzhou, China. Through years’ cultivation in clinical in-vitro diagnostic field, Medmay has gradually developed an unique corporate culture-“Pursuit of Excellence”. Till now, Products created from Medmay have won long-term supports from thousands of customers in more than 100 countries around the world. In recent years, Medmay has already set foot into the field of medical consumables and general laboratory equipments. Constantly upholding the spirit of “Pursuit of Excellence”, Medmay cooperates in depth with hundreds of high grade manufacturers by carefully screening, and has already launched series of high-quality products to meet with any demands from customers continuously. At the time bringing increases of efficiency, quality and service to customers, Medmay has also achieved rapid development. Medmay aim to create value for world's customers in all focused fields, and prove to be a long-term worth trusting cooperative partner.
51 to 200 staff
Grandomics Biosciences
GrandOmics focuses on the application of long-read sequencing technologywe developed sequencing solutions for different biology research fields by integrating the advantages of multiple sequencing platforms, including NGS and Long-read Sequencing. GrandOmics also actively engaged in the independent development of bioinformatics software and explore the application of long-read sequencing technology in clinical medicine. In response to the data processing problems of the long read sequencing technology in the application fields of animal and plant genome research, pathogenic microorganism detection, and clinical testing, we have developed NextDenovo, NextPolish, GrandBox, GrandPathogen and other bio-information algorithms and platforms to analysis genomic data. Contact us now at inquiry@grandomics.com. We are so glad to assist your genomics research – we’d love to hear from you!
51 to 200 staff
Seekin Inc
Cancer early detection is probably the most cost-effective means to reduce cancer mortality as prognosis is much better when cancer is detected and treated at the early stage. SeekIn is a startup focusing on blood-based pan cancer early diagnosis with a mission to reduce cancer mortality by 10% in the screened population by 2030. Our proprietary ctDNA mutation detection technology has demonstrated its promise to identify asymptomatic cancer patients from general population.
11 to 50 staff
Tianjin Cansino Biotechnology Inc
Tianjin CanSino Biotech Inc. is an emerging biotechnology company dedicated to vaccine research, development and commercialization. We seek to address the pressing unmet medical needs by developing and marketing leading-edge, high quality vaccines for China and other emerging markets at affordable prices. CanSino has established bacterial and cell/viral culture pilot facilities in compliance to the current GMP standard. We can provide service to our clients and partners for clinical trial material production.
51 to 200 staff
Ts-Biotech
As a global leading biotechnology innovator, TS-Biotech links white technology to ingredient solutions and serves the health and personal care industries. We respect the marvelous nature providing our expertise from upcycling naturals to biotechnology, our core research pillars. Our talented and reliable team members pioneer with passion and creativity sustainable and effective future solutions for the wellness of human beings. Thanks to our expertise in R&D and industrial process control, efficacy-proven active ingredients sprout to energize innovation in the market. Contact sales@ts-biotech.com
51 to 200 staff
